EYPT icon

EyePoint Pharmaceuticals
EYPT

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$25
113% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Chardan Capital
Chardan Capital
Daniil Gataulin
33% 1-yr EYPT win rate
7 Aug ‘25 2 months ago
HC Wainwright & Co
HC Wainwright & Co
Yi Chen
67% 1-yr EYPT win rate
6 Aug ‘25 2 months ago